How can innovation improve male reproductive health? From new approaches to male contraception to treatments for infertility, two Danish startups are working to address challenges that have traditionally received limited attention.

For the November edition of Ventures & Wine, founders from XY Therapeutics and VasDeBlock Medical will share their work and perspectives on emerging opportunities in male reproductive health.

The speakers will share insights into the science behind their technologies, their experiences building early-stage companies, and the challenges of translating research into practical medical solutions.

The evening will also offer an opportunity to meet others working across science, entrepreneurship and life sciences, exchange ideas and make new connections.

Speakers

Lasse Nørregaard – Co-founder and CBO, XY Therapeutics

XY Therapeutics is developing a novel treatment for male infertility, with the aim of improving sperm production and function.

Niels Lindeburg – Founder and CTO, VasDeBlock Medical

VasDeBlock Medical is developing a hormone-free, non-surgical and reversible alternative to vasectomy, offering a new approach to male contraception.